Published in Hepatitis Weekly, December 10th, 2001
Ribavirin (Rebetol capsules) is now part of the combination therapy that represents the most effective treatment currently available for this infection. The data were presented November 12, 2001, at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting in Dallas, Texas.
New data on Levovirin, a L-isomer of ribavirin, which has been shown to have similar immunomodulatory activity as ribavirin but with a much safer profile, were also presented at...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.